F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market October 19, 2022 Get link Facebook X Pinterest Email Other Apps The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective. BY CHRISTINA JEWETT | NYTimes Health | Disclosure Comments
Comments
Post a Comment